medRxiv : the preprint server for health sciences · 2025
QRS 3D Voltage-Time Integral in Narrow QRS Complex - Establishing the Normal Reference Range.
СтатьяПрепринтНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gupta Amulya, Harvey Christopher J, Mahmood Uzair, Baer Jacob D, Parimi Nikhil, Bapat Ashutosh, Sheldon Seth H, Reddy Madhu, Yao Zijun, Lee Yongkuk, Noheria Amit
Аннотация
BACKGROUND: Vectorcardiographic 3D QRS voltage-time integral (VTIQRS-3D) is a novel marker of ventricular dyssynchrony pertinent for cardiac resynchronization therapy. It may have additional clinical utility but its normal reference ranges have not been established. We sought to define reference ranges for VTIQRS-3D in healthy individuals.
METHODS: We retrospectively analyzed 12-lead ECGs of healthy adults (2010-2014) and compared them to patients with cardiomyopathy with reduced ejection fraction (EF) <50%. Using the Kors matrix, 12-lead ECGs with QRS duration ≤120 ms were converted to vectorcardiographic X, Y, and Z leads. VTIQRS-3D was calculated as the instantaneous root-mean-square (3D) voltage integrated over the QRS duration. Reference range limits were defined as the 2.5th to 97.5th percentiles respectively for healthy females and males in age groups 18-34, 35-54 and ≥55 years.
RESULTS: The study included 468 healthy adults (age 44.6 ± 17.0 years; 63.9% female) and 314 patients with cardiomyopathy (age 62.1 ± 14.0 years; 34.4% female). VTIQRS-3D was significantly larger in the cardiomyopathy patients compared to the healthy population (48.2±21.4 vs. 38.1±9.3 μVs, p<0.0001). Increased age and female sex were significant predictors of lower VTIQRS-3D in the healthy population (both p<0.0001). VTIQRS-3D reference ranges for respective age groups for healthy females were 23.2-55.0, 23.9-56.4 and 19.6-50.9 μVs, and for healthy males were 29.9-57.2, 28.2-56.7 and 21.4-55.9 μVs.
CONCLUSION: VTIQRS-3D is higher at younger age in healthy population, male sex and in patients having cardiomyopathy with reduced EF. Age and sex need to be accounted for using VTIQRS-3D as a marker for structural heart disease.
METHODS: We retrospectively analyzed 12-lead ECGs of healthy adults (2010-2014) and compared them to patients with cardiomyopathy with reduced ejection fraction (EF) <50%. Using the Kors matrix, 12-lead ECGs with QRS duration ≤120 ms were converted to vectorcardiographic X, Y, and Z leads. VTIQRS-3D was calculated as the instantaneous root-mean-square (3D) voltage integrated over the QRS duration. Reference range limits were defined as the 2.5th to 97.5th percentiles respectively for healthy females and males in age groups 18-34, 35-54 and ≥55 years.
RESULTS: The study included 468 healthy adults (age 44.6 ± 17.0 years; 63.9% female) and 314 patients with cardiomyopathy (age 62.1 ± 14.0 years; 34.4% female). VTIQRS-3D was significantly larger in the cardiomyopathy patients compared to the healthy population (48.2±21.4 vs. 38.1±9.3 μVs, p<0.0001). Increased age and female sex were significant predictors of lower VTIQRS-3D in the healthy population (both p<0.0001). VTIQRS-3D reference ranges for respective age groups for healthy females were 23.2-55.0, 23.9-56.4 and 19.6-50.9 μVs, and for healthy males were 29.9-57.2, 28.2-56.7 and 21.4-55.9 μVs.
CONCLUSION: VTIQRS-3D is higher at younger age in healthy population, male sex and in patients having cardiomyopathy with reduced EF. Age and sex need to be accounted for using VTIQRS-3D as a marker for structural heart disease.